Global Surgical Robots Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

Global Surgical Robots Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

The Global surgical robots market is expected to grow by registering a CAGR of 16.9% during the forecast period. Robotic procedures boost dexterity, improve visualization, and restore appropriate hand-eye coordination and posture. Additionally, these devices enable surgeries that were previously technically challenging or impractical. These are the primary forces influencing the market.

Key Highlights

• The rising demand for automation in the healthcare sector, growing incidences of chronic diseases, increasing geriatric population, the complexity of surgical procedures, and the growing need for non-invasive surgeries with more precision and flexibility are driving the market studied. Despite this, several surgeons and engineers working on robotic surgical systems for the Army eventually formed commercial ventures that introduced robotics to the civilian surgical community.
• The use of robotic equipment is common in minimally invasive procedures. Small incisions are used throughout these procedures, as the name would suggest. This method typically results in less discomfort, less blood loss, shorter hospital stays, and quicker recoveries, which enables surgeons to perform difficult-to-reach body sections and gain a better view of obscured areas, encouraging patients worldwide to choose robotic surgery, which boosts the market.
• Cancer cases are also aiding the growth of the market. According to National Cancer Institute, the number of cancer incidences is estimated to reach 22 million by 2030; 60% of the cases are expected to occur in Africa, Asia, and Central & South American regions. With advancements in medical diagnostics, cancer detection has become easy. Thus, patients are now opting for surgical procedures to remove the tumor.
• High installation costs and concerns regarding safety and integration issues are challenging the market’s growth. However, innovations in the surgical robot landscape are expected to reduce the cost of the systems over the coming years. Thus, market penetration is projected to increase over the forecast period.
• The COVID-19 pandemic has impacted multiple layers of society, including frontline workers and, in particular, those in direct contact with patients exposed to major risks. Medical services have been primarily restricted, including the cancellation of elective surgeries, to combat pathogen spread and protect healthcare workers and patients. This factor poses a considerable burden for patients and immense economic loss for several hospitals. Using the robot as a shielding layer separating the healthcare worker and the patient is an important tool to combat the fear of pathogens and maintain surgical volumes.
• There was massive stress on the healthcare system during the pandemic, particularly on surgical facilities, respirators, and intensive care unit (ICU) beds. These resources are limited in a hospital that may face a sudden patient influx, resulting in the reorganization of ICU beds and the cancelation of elective procedures. There was also the risk of infectious spread among healthcare providers and patients.

Key Market TrendsNeurosurgery to Hold Substantial Market Share

• The adoption rate of surgical robots in neurosurgery is not prevalent compared to other areas of medicine, such as urology and cardiology. The anatomical challenges in such a complex and spatially limited organ have impacted the growth rate, in addition to the fact that the brain includes extremely sensitive tissues. Despite this, the demand for these surgical robots has also been driven by factors like the aging population and a lack of healthcare professionals.
• The growth of the neurosurgery segment is imminent due to the increasing prevalence of neurological disorders, such as strokes, neurodegenerative diseases, epilepsy, chronic migraine, and others, and the growing adoption rates of innovative technologies by physicians.
• Moreover, developments in this space have been providing the required impetus for market growth. For instance, in February 2021, Aesculap, Inc. announced its receipt of FDA 510(k) clearance for DIR800 3D digital infrared fluorescence, which is used in viewing intraoperative blood flow in the cerebral vascular area, including, but not limited to, assessing cerebral aneurysm and vessel branch occlusion, as well as patency in neurosurgery.​
• Similarly, in January 2021, robotic neurosurgery was conducted by Dr. Manas Panigrahi, Consultant Neurosurgeon at RIMS Hospitals, India, to detect seizures center in a 9-year-old boy's brain. The robotic system also assists in various brain surgeries, including stereotactic guided brain tumor biopsy, Epilepsy surgery, brain tumor surgery to identify important and difficult parts of the brain, and Parkinson's disease. While robot-guided neurosurgery is already available in a few cities worldwide, countries such as India have only 3-4 cities that have robotic neurosurgery in their practice. This signifies potential growth opportunities.
• Therefore, the global neurosurgery market is driven by several factors that contribute to the market's growth. The primary drivers of the market include the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease (AD), and PD and the popularity of navigation with multimodality imaging. Also, the increase in the demand for MI endovascular surgeries and technological advances are expected to contribute significantly to the market's growth.

Asia-Pacific to Witness the Highest Growth

• Asia-Pacific is projected to record the highest growth rate due to the increasing demand in India, China, and Japan and the growth of the region's overall robotics market. In China, the demand for surgical robots is mainly among a niche group of wealthier patients who can afford expensive procedures. However, the advent of domestic versions has decreased the prices, which is expected to drive the deployment.​
• Asian countries, particularly Japan, China, and South Korea, with substantial investment in technological advancements, serve as new revenue pockets for the medical robotic systems markets.​
• The healthcare industry is increasingly benefitting from the introduction of novel surgical robots since these machines have been gaining clinical approval for challenging surgical operations. According to a survey conducted by the IEEE (an association for electronic engineering), surgical robots are gaining increased acceptance by millennial parents in Asian countries compared to individuals in the United States and the United Kingdom. This trend is well justified as Asia-Pacific is anticipated to witness aggressive growth during the forecast period.​
• Minimally invasive surgical robots are widely used in urology, cardiothoracic surgery, gynecology, general surgery, and other fields due to their simple operation, high surgical accuracy, and adequate postoperative results.​ In addition, the companies in the region have gradually started leasing robots to hospitals to increase the uptake of products and promote growth despite the high initial and maintenance cost of these robots.
• Manufacturers are collaborating with technologists to improve the efficacy of robots that contribute to better patient outcomes. Companies are increasing their AI and machine learning effectiveness to make surgical robots a mainstream technique in operating rooms worldwide.​ Moreover, some of the leading companies in surgical robots have set up their research and development centers in the region. For instance, Medtronic operates two Research and Development Centers in India located in Bangalore and Hyderabad.

Competitive Landscape

The Global surgical robot market gained a competitive edge in recent years. The major firms with a sizable market share are concentrating on growing their consumer bases abroad. To grow their market shares and profitability, the corporations are using strategic joint ventures and mergers and acquisitions.

• August 2022 - THINK Surgical, Inc., an innovator in orthopedic surgical robots, announced entering into a development and distribution agreement with South Korea-based Curexo, Inc., a medical robotics specialist company.
• June 2022 - Intuitive, a global technology innovator in minimally invasive care and the pioneer of robotic-assisted surgery, announced that the U.S. Food and Drug Administration had cleared the integration of a mobile cone-beam CT (CBCT) imaging technology and the Ion Endoluminal System used for robotic-assisted bronchoscopy.
• January 2022 - CMR Surgical, engaged in the surgical robotics business, has announced the successful completion of high-volume urological procedures at the Sindh Institute of Urology and Transplantation (SIUT) using the next-generation surgical robotic system, Versius, in Pakistan.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.